miR-497-5p promoted neuronal injury in ischemic stroke by inhibiting the BDNF/TrkB/PI3K/Akt pathway

Chunyan Gong1, Xiaona He1, Guiliang Li1

  • 1Department of Rehabilitation Medicine, Qujing No. 1 Hospital, Qujing, Yunnan, China.

PubMed

Insights

MicroRNA-497-5p worsens brain injury after stroke by blocking the BDNF/TrkB/Akt pathway. Inhibiting miR-497-5p may protect neurons from ischemic stroke damage.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Ischemic stroke causes significant neuronal injury.
  • MicroRNAs (miRNAs) play crucial roles in regulating cellular processes, including neuronal survival and death.
  • The specific role of miR-497-5p in ischemic stroke remains to be fully elucidated.

Purpose of the Study:

  • To investigate the molecular mechanism of miR-497-5p in regulating neuronal injury following ischemic stroke.
  • To explore the involvement of the Brain-Derived Neurotrophic Factor (BDNF)/Tropomyosin receptor kinase B (TrkB)/Akt signaling pathway in this process.

Main Methods:

  • Established an in vitro ischemic stroke model using PC12 cells subjected to oxygen-glucose deprivation/reoxygenation (OGD/R).
  • Quantified miR-497-5p expression using RT-qPCR.
  • Assessed cell viability (CCK-8), apoptosis, and reactive oxygen species (ROS) via flow cytometry.
  • Measured oxidative stress markers (MDA and SOD).
  • Verified the interaction between miR-497-5p and BDNF using a dual-luciferase reporter assay.
  • Analyzed protein expression levels of BDNF, TrkB, p-TrkB, Akt, and p-Akt through Western blotting.

Main Results:

  • OGD/R treatment significantly decreased miR-497-5p expression in PC12 cells.
  • Downregulation of miR-497-5p exacerbated OGD/R-induced neuronal injury, increasing apoptosis and ROS, while decreasing cell viability and SOD activity.
  • miR-497-5p was confirmed to directly target and inhibit BDNF expression.
  • Overexpression of BDNF attenuated OGD/R-induced apoptosis and oxidative stress.

Conclusions:

  • miR-497-5p aggravates neuronal injury in an experimental ischemic stroke model.
  • This detrimental effect is mediated by the inhibition of the BDNF/TrkB/Akt signaling pathway.
  • Targeting miR-497-5p may represent a potential therapeutic strategy for ischemic stroke.